3P51 Stock Chart & Stats
€2.77
€0.03(0.94%)
At close: 4:00 PM EDT
€2.77
€0.03(0.94%)
Day’s Range― - ―
52-Week Range€2.37 - €2.87
Previous CloseN/A
Volume0.00
Average Volume (3M)673.00
Market Cap
€1.82B
Enterprise Value€3.48K
Total Cash (Recent Filing)€58.52M
Total Debt (Recent Filing)€902.60M
Price to Earnings (P/E)16.1
Beta0.11
Next Earnings
Nov 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.26
Shares Outstanding652,720,460
10 Day Avg. Volume192
30 Day Avg. Volume673
Financial Highlights & Ratios
PEG Ratio0.41
Price to Book (P/B)1.59
Price to Sales (P/S)16.13
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€3.27Price Target Upside18.13% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.12
Revenue Forecast (FY)€112.63M
Bulls Say, Bears Say
Bulls Say
Defensive Healthcare Rental ModelHealthcare-focused properties and contractual leases support recurring rental income and reduce reliance on discretionary consumer demand. Singapore hospitals and Japanese nursing homes also provide asset and geographic diversification.
Renewed Revenue GrowthThe return to stronger revenue growth suggests resilient tenant demand and improving rental performance. Sustained growth in healthcare real estate can support net property income and distributions if operating costs remain controlled.
Moderate LeverageModerate leverage and a growing equity base provide financial stability for a property trust. Broadly steady debt alongside expanding assets may preserve borrowing capacity for acquisitions or asset enhancements.
Bears Say
Uncertain Free Cash FlowVolatile free cash flow weakens visibility into cash available after capital needs and distributions. The reported zero in 2025 raises uncertainty about current cash conversion and could constrain funding flexibility.
Uneven Earnings QualityLarge swings in reported profit make underlying operating performance harder to assess and reduce confidence in earnings as a stable measure of distributable income. Non-recurring effects may overstate sustainable profitability.
Profitability PressureLower EBIT despite revenue growth points to cost pressure or normalization, while inconsistent ROE indicates uneven returns on the capital base. Persistent pressure could limit growth in distributable earnings.
Parkway Life Real Estate Investment News
3P51 FAQ
What was Parkway Life Real Estate Investment Trust’s price range in the past 12 months?
Parkway Life Real Estate Investment Trust lowest stock price was €2.37 and its highest was €2.87 in the past 12 months.
What is Parkway Life Real Estate Investment Trust’s market cap?
Parkway Life Real Estate Investment Trust’s market cap is €1.82B.
When is Parkway Life Real Estate Investment Trust’s upcoming earnings report date?
Parkway Life Real Estate Investment Trust’s upcoming earnings report date is Nov 04, 2026 which is in 72 days.
How were Parkway Life Real Estate Investment Trust’s earnings last quarter?
Parkway Life Real Estate Investment Trust released its earnings results on Aug 03, 2026. The company reported €0.055 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Parkway Life Real Estate Investment Trust overvalued?
According to Wall Street analysts Parkway Life Real Estate Investment Trust’s price is currently Undervalued.
Does Parkway Life Real Estate Investment Trust pay dividends?
Parkway Life Real Estate Investment Trust does not currently pay dividends.
What is Parkway Life Real Estate Investment Trust’s EPS estimate?
Parkway Life Real Estate Investment Trust’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Parkway Life Real Estate Investment Trust have?
Parkway Life Real Estate Investment Trust has 652,720,460 shares outstanding.
What happened to Parkway Life Real Estate Investment Trust’s price movement after its last earnings report?
Parkway Life Real Estate Investment Trust reported an EPS of €0.055 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.628%.
Which hedge fund is a major shareholder of Parkway Life Real Estate Investment Trust?
Currently, no hedge funds are holding shares in DE:3P51
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Parkway Life Real Estate Investment Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.72%
12-Months-Change
Fundamentals
Return on Equity
1.91%
Trailing 12-Months
Asset Growth
-0.19%
Trailing 12-Months
Company Description
Parkway Life Real Estate Investment Trust
Parkway Life Real Estate Investment Trust (PLife REIT) is recognized as one of Asia's foremost publicly listed healthcare REITs based on its significant asset holdings. The trust's investment strategy focuses on acquiring income-generating real estate and associated assets predominantly utilized for healthcare and related services. This comprehensive mandate covers hospitals, various medical facilities, and properties supporting healthcare research, education, and the production or warehousing of pharmaceuticals, medical goods, and devices. As of December 31, 2020, PLife REIT managed a robust and geographically diversified portfolio comprising 54 properties across the Asia Pacific region, with a total valuation of approximately S$2.02 billion. Its Singaporean assets include the largest collection of strategically located private hospitals: Mount Elizabeth Hospital, Gleneagles Hospital, and Parkway East Hospital. Furthermore, its Japanese holdings encompass 50 high-quality nursing home and care facilities situated in various prefectures. The trust also possesses strata-titled units within the MOB Specialist Clinics in Kuala Lumpur, Malaysia.
3P51 Stock 12 Month Forecast
Average Price Target
€3.27
▲(18.13% Upside)
Technical Analysis
Keppel REIT
―
Ascott Residence
―
CDL Hospitality Trusts
―
First Real Estate Investment
―
Suntec Real Estate Investment
―






